跳至主要内容
临床试验/IRCT20171123037600N1
IRCT20171123037600N1已完成3 期

Evaluation of Curcumin as add-on therapy in patients with Parkinson's disease on MDS-UPDRS scale: A Randomized Double-blind Placebo-controlled Trial

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 no limit(—)
性别
All

入选标准

  • Patients who are diagnosed with Parkinson's disease based on MDS clinical diagnostic criteria for Parkinson's disease and at least 30 years of age
  • Patients who are receiving dopaminergic treatment and their symptoms are under control
  • Patients with signed informed consent

排除标准

  • Severe systemic or psychologic disease
  • History of Gastrointestinal bleeding
  • Aspirin use over 325mg/day, any anticoagulant or anti-platelet drug use such as heparin or warfarin, antioxidant use except vitamin E up to 2000 IU/day and vitamin C up to 500mg/day

研究者

相似试验